Recent report, however, shows that CK1γ2 may be implicated in chronic lymphocytic leukemia (CLL) and other B cell lymphomas as one of the targets of microRNA-155 [59]. The gene discussed is CSNK1G2; the disease is B-cell chronic lymphocytic leukemia.